Live
Read now

Canary Oncoceutics, Inc.

Precision Diagnostics. Healthier Outcomes

health AImedtechprecision oncologymolecular diagnostics
Employees10
LocationPhoenix, AZ

About

Canary Oncoceutics, Inc. is a Company Focused on Adding Predictive Information to Personalized Cancer Diagnostics. We utilize the latest sequencing technology coupled with AI/ML and proprietary methods to give patients and clinicians the tools to make optimal decisions for cancer care.

Product

Value proposition
Providing patients and healthcare professionals with cutting-edge genomics and precision oncology to empower personalized cancer therapy and informed treatment decisions.
Target customers
healthcare professionals, patients, and caregivers in the US (and globally)

Founders

  • Harry M. Lander

Products

Canary FocusCanary StatCanary HRDStat Heredit

Key features

Comprehensive genomic profiling for cancerCompanion diagnostic developmentAI-driven cancer detection and insightsGenomic testing for actionable insightsSupportive expert guidance from oncologists

Technologies

genomicsAImolecular profilingcompanion diagnostics

Certifications

HIPAA-compliant & secure

Partnerships

strategic partnerships with patient advocacy organizations, medical centers, and researchers

Investors

NorthBridge PE

News

Browse similar startups

Related startups

Profile updated Jul 29, 2026. Sources: canaryonco.com

ClinAdsby ClinsightBuilt for clinics

Your clinic’s marketing team, powered by AI.

On-brand ads, SEO, and social campaigns in one place.

Generate your first clinic ad for free
Clincyby ClinsightBuilt for practices

Get more revenue from the patients you already have.

Voice and SMS that follow up until lapsed patients are back on the schedule.

Book a Clincy call
DDS RecruitPowered by ClinsightDental recruiting

Your practice’s fractional recruiting team.

Dental-only search, run end to end, with placements guaranteed for a year.

Find your next hire